{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:27:34Z","timestamp":1775197654619,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2158,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1111\/j.1469-0691.2009.02976.x","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T07:12:11Z","timestamp":1252566731000},"page":"26-32","source":"Crossref","is-referenced-by-count":50,"special_numbering":"S5","title":["The role of iron and iron chelators in zygomycosis"],"prefix":"10.1016","volume":"15","author":[{"given":"A.S.","family":"Symeonidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2009.02976.x_bib1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2007-03-076737","article-title":"Iron chelation and regulation of the cell cycle: 2 mechanisms of inhibitor p21CIP1\/WAF1 by iron depletion posttranscriptional regulation of the universal cyclin-dependent kinase","volume":"110","author":"Dong","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1099\/jmm.0.46386-0","article-title":"Natural resistance, iron and infection: a challenge for clinical medicine","volume":"55","author":"Bullen","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-3782(00)00086-4","article-title":"Lactoferrin is responsible for the fungistatic effect of human milk","volume":"59","author":"Andersson","year":"2000","journal-title":"Early Hum Dev"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib4","series-title":"\u2018Iron and infection.\u2019 Molecular, physiological and clinical aspects","first-page":"327","article-title":"Iron binding proteins and host defence","author":"Bullen","year":"1999"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0014-5793(88)81061-5","article-title":"Bleomycin detectable iron in serum from leukaemic patients before and after chemotherapy","volume":"241","author":"Halliwell","year":"1988","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/lt.20827","article-title":"Association of hepatic iron overload with invasive fungal infection in liver transplant recipients","volume":"12","author":"Alexander","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/0006-2952(94)90314-X","article-title":"Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus","volume":"47","author":"de Locht","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1556\/AMicr.52.2005.2.4","article-title":"Iron gathering of opportunistic pathogenic fungi. A mini review","volume":"52","author":"Nyilasi","year":"2005","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.288.5468.1062","article-title":"A high-affinity iron permease essential for Candida albicans virulence","volume":"288","author":"Ramanan","year":"2000","journal-title":"Science"},{"issue":"Pt 1","key":"10.1111\/j.1469-0691.2009.02976.x_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1099\/mic.0.2006\/000927-0","article-title":"The iron- and cAMP-regulated gene SIT1 influences ferrioxamine B utilization, melanization and cell wall structure in C. neoformans","volume":"153","author":"Tangen","year":"2007","journal-title":"Microbiology"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib11","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1128\/IAI.73.9.5493-5503.2005","article-title":"The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence","volume":"73","author":"Hissen","year":"2005","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1128\/IAI.72.3.1402-1408.2004","article-title":"Survival of Aspergillus fumigatus in serum involves removal of iron from transferrin: the role of siderophores","volume":"72","author":"Hissen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib13","doi-asserted-by":"crossref","first-page":"26723","DOI":"10.1074\/jbc.270.45.26723","article-title":"Siderophores: structure and function of microbial iron transport compounds","volume":"270","author":"Neiland","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib14","first-page":"1195","article-title":"Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection","volume":"3","author":"Schrett","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib15","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1128\/IAI.69.12.7671-7678.2001","article-title":"Potential role for extracellular glutathione-dependent ferric reductase in utilization of environmental and host ferric compounds by Histoplasma capsulatum","volume":"69","author":"Timmerman","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/IAI.65.2.434-438.1997","article-title":"Ferric iron reduction by Cryptococcus neoformans","volume":"65","author":"Nyhus","year":"1997","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1288\/00005537-199206000-00011","article-title":"Intracranial complications of mucormycosis: an experimental model and clinical review","volume":"102","author":"Anand","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10096-003-1035-y","article-title":"Mucormycosis: ten-year experience at a tertiary-care center in Greece","volume":"22","author":"Petrikkos","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1701885","article-title":"Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis","volume":"24","author":"Maertens","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archopht.1997.01100160089018","article-title":"Iron overload is a risk factor for zygomycosis","volume":"115","author":"McNab","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib23","first-page":"EIM13","article-title":"A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy","volume":"88","author":"Kubota","year":"2003","journal-title":"Haematologica"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib24","first-page":"129","article-title":"Development of arterial thrombus of Mucorales hyphae during deferoxamine therapy in a patient with aplastic anemia in transformation to myelodysplastic syndrome [in Japanese]","volume":"41","author":"Miyata","year":"2000","journal-title":"Rinsho Ketsueki"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib25","first-page":"169","article-title":"Cloning and functional characterization of the Rhiz. oryzae high affinity iron permease (rFTR1) gene","volume":"235","author":"Fu","year":"2004","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1469-0691.2007.01932.x","article-title":"High-affinity iron permease (FTR1) gene sequence-based molecular identification of clinically important Zygomycetes","volume":"14","author":"Nyilasi","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0272-6386(12)80606-8","article-title":"Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry","volume":"18","author":"Boelaert","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib28","first-page":"561","article-title":"Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine","volume":"41","author":"Kaneko","year":"1991","journal-title":"Acta Pathol Jpn"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib29","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI116419","article-title":"Mucormycosis during deferoxamine therapy is a siderophore mediated infection: in-vitro and in-vivo animal studies","volume":"91","author":"Boelaert","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1439-0507.1993.tb00680.x","article-title":"Effect of ferrioxamine on the growth of Rhizopus","volume":"36","author":"Verdonck","year":"1993","journal-title":"Mycoses"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ki.1994.89","article-title":"Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect","volume":"45","author":"Boelaert","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/ndt\/7.9.931","article-title":"Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of deferrioxamine in haemodialysis patients","volume":"7","author":"Verpooten","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib33","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1182\/blood-2006-02-002394","article-title":"Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions","volume":"107","author":"Neufeld","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/dkl350","article-title":"Deferiprone iron chelation as a novel therapy for experimental mucormycosis","volume":"58","author":"Ibrahim","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib35","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib36","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/AAC.01065-06","article-title":"Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis","volume":"50","author":"Reed","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02976.x_bib37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1128\/AAC.01611-07","article-title":"Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis","volume":"52","author":"Soummer","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14607242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14607242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T23:18:50Z","timestamp":1590103130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14607242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":37,"alternative-id":["S1198743X14607242"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02976.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}